Catalyst Pharmaceuticals (CPRX) News Today $24.49 +0.38 (+1.58%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$24.34 -0.15 (-0.59%) As of 05/23/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CPRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period 20,917 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Bought by Teza Capital Management LLCTeza Capital Management LLC purchased a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 20,917 shares of the biopharmaceuticMay 22 at 5:25 AM | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Acquired by Man Group plcMan Group plc increased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 24.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 315,817 shares of the biopharmaceutical company's stock after acMay 22 at 4:34 AM | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Deutsche Bank AGDeutsche Bank AG reduced its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 65.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 200,395 shares of the biopharmaceutical company's stock after selling 377,813 shares during the quartMay 22 at 3:53 AM | marketbeat.comTema Etfs LLC Acquires Shares of 11,352 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Tema Etfs LLC acquired a new stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,352 shares of the biopharmaceuticaMay 21 at 5:59 AM | marketbeat.comLazard Asset Management LLC Purchases 46,318 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Lazard Asset Management LLC increased its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 58.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 125,343 shares of the biopharmaceutiMay 19, 2025 | marketbeat.comJanus Henderson Group PLC Increases Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Janus Henderson Group PLC boosted its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 32.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 476,023 shares of the biopharmaceutical company's stMay 19, 2025 | marketbeat.comBank of America Corp DE Raises Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Bank of America Corp DE raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 139.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,568,791 shares of the biopharmaceutical company's stock after buying an adMay 19, 2025 | marketbeat.comBNP Paribas Financial Markets Has $2.67 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)BNP Paribas Financial Markets lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 16.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 127,679 shares of the biopharmaceutical company's stock after selling 25,571 sMay 18, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Gary Ingenito Sells 44,000 SharesMay 16, 2025 | insidertrades.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. lowered its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 13.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 912,999 shares of the biopharmaceutical company's stock afterMay 15, 2025 | marketbeat.comThe Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The BusinessMay 14, 2025 | finance.yahoo.comIntegral Health Asset Management LLC Cuts Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Integral Health Asset Management LLC trimmed its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 25.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 300,000 shares of theMay 14, 2025 | marketbeat.comAlgert Global LLC Boosts Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Algert Global LLC lifted its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 185.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 47,920 shares of the biopharmaceutical company's stock after bMay 13, 2025 | marketbeat.comNorthern Trust Corp Acquires 119,766 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Northern Trust Corp raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 8.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,503,566 shares of the biopharmaceutical company's stock after buying an additioMay 13, 2025 | marketbeat.comCoreCap Advisors LLC Buys 35,480 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)CoreCap Advisors LLC raised its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 8,870.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 35,880 shares of the biopharmaceutical company'May 12, 2025 | marketbeat.com207,733 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Acquired by Clark Capital Management Group Inc.Clark Capital Management Group Inc. purchased a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 207,733 shares of the biopharmaceuMay 11, 2025 | marketbeat.comDeerfield Management Company L.P. Series C Has $65.39 Million Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Deerfield Management Company L.P. Series C lowered its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 49.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,133May 10, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comCatalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...May 9, 2025 | finance.yahoo.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Capstone Investment Advisors LLCCapstone Investment Advisors LLC lowered its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 54.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,173 shares of the biopharmaceutical compaMay 9, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Invests $1.52 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Schonfeld Strategic Advisors LLC purchased a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 72,980 shares ofMay 9, 2025 | marketbeat.comAQR Capital Management LLC Has $9.96 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)AQR Capital Management LLC raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 3.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 477,011 shares of the biopharmaceuticalMay 9, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Recommendation of "Buy" by BrokeragesCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) has received a consensus rating of "Buy" from the eight research firms that are covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strMay 8, 2025 | marketbeat.comTudor Investment Corp ET AL Purchases Shares of 59,552 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Tudor Investment Corp ET AL acquired a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 59,552 shares of the biopharmaceutical company's stock, valueMay 8, 2025 | marketbeat.comVoya Investment Management LLC Purchases 10,465 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Voya Investment Management LLC boosted its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 24.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 52,416 sMay 8, 2025 | marketbeat.comCatalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business UpdateMay 7, 2025 | globenewswire.comCastlekeep Investment Advisors LLC Makes New Investment in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Castlekeep Investment Advisors LLC bought a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,796,552 shares of the biopharmaceutical compMay 7, 2025 | marketbeat.comHsbc Holdings PLC Has $764,000 Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Hsbc Holdings PLC lifted its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 64.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,337 shares of the biopharmaceuticMay 7, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Aquatic Capital Management LLCAquatic Capital Management LLC trimmed its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 38.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,261 shares of the biopharmaceutical company's stMay 4, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Has $25.37 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Price T Rowe Associates Inc. MD lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,215,438 sharesMay 3, 2025 | marketbeat.comCatalyst Pharmaceuticals (CPRX) to Release Earnings on WednesdayCatalyst Pharmaceuticals (NASDAQ:CPRX) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-catalyst-pharmaceuticals-inc-stock/)May 2, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $1.34 Million Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Envestnet Asset Management Inc. lifted its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 162.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 64,395 shares of the biopharmaceutMay 2, 2025 | marketbeat.comBoothbay Fund Management LLC Cuts Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Boothbay Fund Management LLC lessened its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 27.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,865 shares ofMay 1, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Holdings Lifted by Tower Research Capital LLC TRCTower Research Capital LLC TRC increased its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 242.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,491 shareMay 1, 2025 | marketbeat.comIs Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?April 30, 2025 | finance.yahoo.comCatalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025April 30, 2025 | globenewswire.comJump Financial LLC Decreases Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Jump Financial LLC cut its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 59.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,074 shares of the biopharmaceutical company'April 29, 2025 | marketbeat.comWells Fargo & Company MN Sells 73,111 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Wells Fargo & Company MN cut its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 46.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 82,820 shares of the biopharmaceutical company's stock after selling 73,111 shApril 28, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy NowApril 27, 2025 | msn.comCanada Pension Plan Investment Board Invests $1.24 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Canada Pension Plan Investment Board bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 59,600 shares of the biopharmaceutical company's stockApril 27, 2025 | marketbeat.comWalleye Capital LLC Sells 234,105 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Walleye Capital LLC lessened its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 94.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,183 shares of the biopharmaceutical companApril 27, 2025 | marketbeat.comFirst Trust Advisors LP Cuts Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)First Trust Advisors LP decreased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 8.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,233,834 shares of the biopharmaceutical company's stock after selling 195,13April 26, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Marshall Wace LLPMarshall Wace LLP cut its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 70.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 253,637 shares of the biopharmaceutical company's stock after selling 607,297 shares during the peApril 26, 2025 | marketbeat.comRaymond James Financial Inc. Purchases Shares of 329,980 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Raymond James Financial Inc. acquired a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 329,980 shares of the biophApril 26, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Purchases New Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 116,758 shares of the biopharmaceutical company's stock, valuedApril 24, 2025 | marketbeat.comCatalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025April 22, 2025 | globenewswire.comMesirow Institutional Investment Management Inc. Decreases Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Mesirow Institutional Investment Management Inc. trimmed its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 7.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 742,295 shares of the biopharmaceutical cApril 22, 2025 | marketbeat.comCatalyst Pharmaceuticals price target raised to $34 from $33 at BofAApril 22, 2025 | markets.businessinsider.comInvesco Ltd. Lowers Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Invesco Ltd. cut its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 9.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 846,851 shares of the biopharmaceutical company's stock aftApril 22, 2025 | marketbeat.comAltium Capital Management LLC Sells 130,000 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Altium Capital Management LLC lessened its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 33.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 255,000 shares of the biophaApril 20, 2025 | marketbeat.com Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPRX Media Mentions By Week CPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼1.650.75▲Average Medical News Sentiment CPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼86▲CPRX Articles Average Week Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTRS News MRNA News ASND News QGEN News ROIV News RVMD News ELAN News BPMC News BBIO News VRNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPRX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
